Head to Head Contrast: Medtronic (MDT) vs. Integer (ITGR)

Medtronic (NYSE: MDT) and Integer (NYSE:ITGR) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.

Analyst Recommendations

This is a summary of current ratings and target prices for Medtronic and Integer, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medtronic 0 10 12 0 2.55
Integer 0 3 1 0 2.25

Medtronic currently has a consensus target price of $88.16, suggesting a potential upside of 8.95%. Integer has a consensus target price of $51.00, suggesting a potential upside of 14.22%. Given Integer’s higher possible upside, analysts plainly believe Integer is more favorable than Medtronic.

Risk & Volatility

Medtronic has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, Integer has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.

Valuation & Earnings

This table compares Medtronic and Integer’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Medtronic $29.71 billion 3.69 $4.03 billion $3.64 22.23
Integer $1.39 billion 1.02 $5.96 million $0.63 70.87

Medtronic has higher revenue and earnings than Integer. Medtronic is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Medtronic and Integer’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Medtronic 16.93% 12.63% 6.51%
Integer 1.42% 11.22% 3.03%

Insider & Institutional Ownership

81.9% of Medtronic shares are held by institutional investors. Comparatively, 95.1% of Integer shares are held by institutional investors. 0.3% of Medtronic shares are held by company insiders. Comparatively, 4.8% of Integer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Dividends

Medtronic pays an annual dividend of $1.84 per share and has a dividend yield of 2.3%. Integer does not pay a dividend. Medtronic pays out 50.5% of its earnings in the form of a dividend. Medtronic has increased its dividend for 39 consecutive years.

Summary

Medtronic beats Integer on 12 of the 17 factors compared between the two stocks.

Medtronic Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company’s subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Integer Company Profile

Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical’s products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets. QiG focuses on developing medical device systems for some of healthcare’s challenges and reflects the Company’s strategic evolution of its product offerings in order to raise the growth and profitability profile of the Company. QiG utilizes a diversified portfolio approach with three investment modes: new medical device systems commercialization, collaborative programs with OEM customers and strategic equity positions in emerging healthcare companies.

What are top analysts saying about Medtronic PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Medtronic PLC and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit